The Lancet

Progress in outcomes for patients with metastatic squamous non-small-cell lung cancer

The use of immunotherapy in patients with various types of cancer has led to dramatic increases in survival. Increased median ...

Altimmune: Competitor Buyouts Plus Regulatory And Clinical Progress

Altimmune continues developing pemvidutide for MASH but has yet to secure a partner or acquisition despite sector M&A ...
startupticker.ch

Swiss medtechs report clinical progress in heart, brain, and urological health

Three Swiss startups at the forefront of addressing cerebral arteries, erectile dysfunction and heart failure have made progress in their clinical journey. While Artiria Medical has treated more than ...
Frontiers

Prevalence, severity, frequency and healthcare resource use of epilepsy among individuals with Rett Syndrome: analysis of data from a Rett Center of Excellence

Background: Individuals with Rett Syndrome (RTT) frequently experience comorbid epilepsy. Few studies have examined the impact of epilepsy healthcare utilization using real-world datasets among RTT.
IEEE

Comparing Text-Based Clinical Risk Prediction in Critical Care: A Note-Specific Hierarchical Network and Large Language Models

Abstract: Clinical predictive analysis is a crucial task with numerous applications and has been extensively studied using machine learning approaches. Clinical notes, a vital data source, have been ...
BioSpace

Lexeo Therapeutics Announces Progress in FDA Discussions for Accelerated Approval Pathway and Positive Interim Clinical Data for LX2006 in Friedreich Ataxia Cardiomyopathy

NEW YORK, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to pioneering novel treatments for cardiovascular diseases, ...